Biomedical
Tissue engineering has expanded significantly following the emergence of microfluidics and bioprinting. Arcanum Group are working closely with industry partners to drive the commercialisation of start-ups to scale ups.
Tissue engineering has expanded significantly following the emergence of microfluidics and bioprinting. Arcanum Group are working closely with industry partners to drive the commercialisation of start-ups to scale ups.
The next chapter in the development of advanced biomanufacturing. At Arcanum Group we work closely with established parties in this exciting and fast-growing area which lends itself to commercialisation in the areas of biomaterials, medical products and therapies, speciality chemicals, and food & beverages. Implementing machine learning and automation to mass production yields incredible efficiencies and innovation.
Sustainable and ethical meat production. Tissue engineering creates 0 carbon, cultured meat that tastes like steak, without the commercial farming of animals and damage to the planet and its ecosystems.